verified SJR 0,589 · Q2 • database Scopus / SJR & Web of Science indexed

Switzerland · S. Karger AG

workspace_premium Q2 — Hematology lock Subscription

Oncology Research and Treatment

Oncology Research and Treatment is a journal indexed in SJR in Hematology and Oncology with an H index of 58. It has an SJR impact factor of 0,589 and it has a best quartile of Q2. It has an SJR impact factor of 0,589.

ISSN: 2296-5270

Publisher: S. Karger AG

Category: Hematology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,589 Q2

H-index 58

Acceptance rate pie_chart

30% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,589

H-index

Docs (year)

Docs 3y

255

Total refs

2346

Cites 3y

328

Citable 3y

235

Cites/Doc 2y

1.12

Ref/Doc

29.33

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Predictors of Early Distant Relapse in Rectal Cancer Patients Submitted to Preoperative Chemoradiotherapy

Tumor-Related Fatigue -an Underestimated Problem

Systemische Chemotherapie des Urothelkarzinoms

Typical Medication Errors in Oncology: Analysis and Prevention Strategies

Tumour Hypoxia: Impact on Biology, Prognosis and Treatment of Solid Malignant Tumours

The Radioprotectors Amifostine and Sodium Selenite Do Not Modify the Radiosensitivity of Rat Rhabdomyosarcomas

The Potential Role of Radiotherapy in the Management of Hepatoid Carcinomas of the Stomach: A Case Report

Taxane in der primären systemischen Therapie des Mammakarzinoms

Time for Progress

Recent Results in Understanding Molecular Pathways in the Medical Treatment of Esophageal and Gastric Cancer

Randomized Clinical Trial: Myths around Elementary Statistical Principles

Proapoptotische Therapie mit Oblimersen (bcl-2-Antisense-Oligonukleotid) -übersicht uber präklinische und klinische Daten

SHOW MORE ARTICLES

Recurrent Ovarian Cancer

Predictive Value of Excision Repair Cross-Complementation Group 1 in the Response to Platinum-Based Chemotherapy in Esophageal Cancer: A Meta-Analysis

Pirarubicin in Advanced Non-Small Cell Lung Cancer

Perspektiven in der Onkologie

Palliative Therapie des Mammakarzinoms

Palliative Therapie des kolorektalen Karzinoms

Operative Therapie des fortgeschrittenen Harnblasenkarzinoms

New Concepts of Staging in Gastrointestinal Tumors as a Basis of Diagnosis and Multimodal Therapy

Neue Chemotherapeutika in der Therapie des fortgeschrittenen Magenkarzinoms

Molecular Markers in Gastrointestinal Cancer: Targeted Therapy and Tailored Chemotherapy

Modified Glasgow Prognostic Score and Carcinoembryonic Antigen Predict Poor Prognosis in Elderly Patients with Colorectal Cancer

Malpractice in Oncology

FAQs

Oncology Research and Treatment has an SJR of 0,589 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Oncology Research and Treatment is 30%.

Oncology Research and Treatment

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Oncology Research and Treatment?

What is the APC / publication cost?

What is the acceptance rate?